Biomarkers in Saliva in Children With Juvenil Idiopathic Arthritis

NCT02223195 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2020-08-05

No results posted yet for this study

Summary

Purpose and aims This as a pilot study that aims to investigate which inflammatory biomarkers can be found in saliva in children with Juvenile Idiopathic Arthritis (JIA).

The hypothesis is that children with JIA will show a different pattern of inflammatory biomarkers in saliva than healthy Children.

The null hypothesis is that there are no differences.

Conditions

  • Juvenile Idiopathic Arthritis

Sponsors & Collaborators

  • Folktandvården Stockholms län AB

    lead OTHER_GOV

Principal Investigators

  • Britt Hedenberg Magnusson, PhD DDS · Karolinska Institutet

Eligibility

Min Age
7 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02223195 on ClinicalTrials.gov